يحاول ذهب - حر
What's the smartest way for NRIs to build assets in India?
August 06, 2025
|Mint Ahmedabad
Planning to invest in stocks, mutual funds or GIFT City products? Here's how they compare
The Indian growth story isn't just a headline—it's a lived experience. The moment a non-resident Indian lands in Mumbai, the Adani Group welcomes them with world-class airport infrastructure. Step outside and there's an Ola cab waiting. At dinner time, Tata salt on the table reminds them yet again of an Indian company's dominance in the growing economy.
India's growth story continues to attract NRI investors. If you're looking to invest in Indian markets, the first step is choosing the right route—stocks, mutual funds, or the GIFT City option. Here's a look at the pros and cons of each.
Demat account
Before applying for a demat account, NRIs first need to sort out their bank account. When an Indian resident turns NRI, they first need to convert their bank account to a non-resident ordinary (NRO) account. They may also open a non-resident external (NRE) account if they wish to manage their foreign earnings in India. The funds in NRE accounts are freely repatriable to foreign countries, while those in NRO accounts have certain restrictions. Note that existing resident accounts cannot be converted to NRE accounts.
PIS and non-PIS accounts
For NRIs investing in India, understanding the difference between a Portfolio Investment Scheme (PIS) account and a non-PIS account is essential. These account types determine how NRIs can access Indian financial markets, especially for investing in stocks and securities.
A PIS account, regulated by the Reserve Bank of India (RBI), is specifically meant for trading in Indian stock markets—buying and selling shares and convertible debentures on recognized stock exchanges. It enables repatriation of funds through an NRE account, though with certain restrictions. Not all banks offer the PIS facility, and opening one requires RBI approval and a relatively cumbersome documentation process.
هذه القصة من طبعة August 06, 2025 من Mint Ahmedabad.
اشترك في Magzter GOLD للوصول إلى آلاف القصص المتميزة المنسقة، وأكثر من 9000 مجلة وصحيفة.
هل أنت مشترك بالفعل؟ تسجيل الدخول
المزيد من القصص من Mint Ahmedabad
Mint Ahmedabad
'If you're on trend, you are in trouble'
Patou creative head Guillaume Henry discusses the essence of couture and why simple is best
4 mins
December 13, 2025
Mint Ahmedabad
GST cuts, easing inflation drive rural demand revival
India’s rural economy expanded and recovered strongly in late 2025, with consumption, incomes and investment improving after a key tax reform and as inflation eased, a survey showed.
2 mins
December 13, 2025
Mint Ahmedabad
Chair man, of the bored
STREAM OF STORIES
3 mins
December 13, 2025
Mint Ahmedabad
Anju Dodiya creates disquieting worlds
Artist Anju Dodiya discusses the ideas, influences and inspiration behind her new solo show, 'The Geometry of Ash'
5 mins
December 13, 2025
Mint Ahmedabad
Bar hopping with Lounge
\"The things that make a cocktail really great are often very simple details—the frozen glass, the lemon twist—that transform two fingers of alcohol into an ice-glazed elixir,\" writes Alice Lascelles in her excellent guide to making cocktails at home, The Cocktail Edit.
1 mins
December 13, 2025
Mint Ahmedabad
New Delhi and France revise 1992 tax treaty
India and France have struck a deal to revise their 1992 treaty which will halve the tax on dividends paid by Indian units to French parents, potentially saving millions for companies with major operations in the South Asian nation, documents show.
1 min
December 13, 2025
Mint Ahmedabad
Ozempic debuts with a ₹2,200-a-week price tag
for chronic weight management, Novo Nordisk is positioning Ozempic as a treatment of type 2 diabetes with weight loss benefits, competing with Eli Lily’s Mounjaro that was launched in India in March.
1 mins
December 13, 2025
Mint Ahmedabad
How 'puri-aloo' and 'chaat' unite Lucknow
Whenever my friends want to eat puri-aloo, they invite themselves over to my home.
5 mins
December 13, 2025
Mint Ahmedabad
Novo Nordisk debuts Ozempic at ₹2,200 a week
Danish drugmaker Novo Nordisk on Friday launched its blockbuster diabetes drug Ozempic in India, with a starting price of ₹2,200 per week.
1 mins
December 13, 2025
Mint Ahmedabad
Govt’s insurance reform allows 100% FDI, composite licences
The government has paved the way for 100% foreign direct investment in the insurance sector, composite licences and easier capital requirements, among others sweeping reforms, as the Union cabinet cleared the enabling legislation, said two officials aware of the matter.
1 mins
December 13, 2025
Listen
Translate
Change font size
